Mattias Persson

Mattias Persson serves as an Adjunct Assistant Professor at Linköping University within the Department of Biomedical and Clinical Sciences, specifically in the Division of Clinical Chemistry and Pharmacology. His academic position places him within the university's medical and life sciences research framework, contributing to the institution's biomedical research portfolio.

Dr. Persson's research interests focus on pharmacological and toxicological mechanisms, particularly in the area of receptor studies and synthetic cannabinoids. His work bridges clinical chemistry with pharmacological research, examining how synthetic compounds interact with biological receptor systems. This research has significant implications for understanding drug mechanisms, potential therapeutic applications, and forensic toxicology assessments of novel psychoactive substances.

His recent publication in Archives of Toxicology demonstrates his active contribution to the field of receptor pharmacology, specifically examining CB1 receptor activity of halogenated indazole synthetic cannabinoid receptor agonists. This work represents cutting-edge research in understanding how modified synthetic cannabinoids interact with the body's endocannabinoid system.